How Has the Contrast Media Injectors Market Evolved Historically and What is its Current Size?
The contrast media injectors market has seen considerable growth due to a variety of factors.
•In recent times, a significant growth has been observed in the market size of contrast media injectors. The market is projected to expand from $1.68 billion in 2024 to $1.79 billion in 2025, with a compound annual growth rate (CAGR) of 6.6%.
Factors contributing to growth during the historic period include a rise in chronic disease cases, the increment in diagnostic imaging procedures, preference for minimally invasive procedures, growth in healthcare infrastructure, and an increase in the aging population.
What is the Forecasted Market Size and CAGR for the Contrast Media Injectors Market?
The contrast media injectors market is expected to maintain its strong growth trajectory in upcoming years.
• The market for contrast media injectors is anticipated to witness substantial growth over the next few years, soaring to a valuation of "$2.53 billion in 2029 at an impressive compound annual growth rate (CAGR) of 9.1%.
Factors contributing to this expansion during the forecast period include an increase in interventional radiology procedures, a surge in cancer incidences, emphasis on patient safety and comfort, broadening of healthcare services globally, and regulatory support and compliance. Key trends that will emerge during the forecast period encapsulate enhancement and connectivity of automated systems, the emergence of dual-head injectors, advancements in injector technology, a heightened focus on patient safety, an uptick in interventional radiology procedures, and superior imaging techniques and modalities.
What Are The Key Drivers Fueling Growth In The Contrast Media Injectors Market?
The escalation in incidences of cancer and cardiovascular disease (CVD) is projected to fuel the expansion of the contrast media injectors market. Cancer results from uncontrolled cell growth that metastasizes to other parts of the body, while cardiovascular disease refers to conditions impacting the heart or blood vessels. The utilization of contrast media injectors is crucial in diagnostic imaging to augment image clarity, patient safety, and enhance blood circulation and tissue perfusion. For example, the American Cancer Society, a leading US-based nonprofit organization engaged in cancer advocacy, reported an increase in cancer cases from 1,898,160 in 2021 to 1,958,310 in January 2023, indicating a 3.16% surge. Consequently, the rise in cancer and cardiovascular disease (CVD) is stimulating the growth of the contrast media injectors market.
What Are The Principal Market Segments In The Global Contrast Media Injectors Industry?
The contrast media injectors market covered in this report is segmented –
1) By Product: Consumables, Injector Systems, Accessories
2) By Type of Injectors: Single Head Injectors, Dual-Head Injectors, Syringe less Injectors
3) By Application: Radiology, Interventional Cardiology, Interventional Radiology
4) By End-user: Hospitals, Diagnostics Centers, Ambulatory Surgery Centers
Subsegments:
1) By Consumables: Syringes, Tubing, Other Consumables
2) By Injector Systems: CT Injectors, MRI Injectors, Angiography Injectors
3) By Accessories: Injector Heads, Software
Pre-Book The Contrast Media Injectors Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Emerging Market Trends Are Altering The Contrast Media Injectors Sector?
The rise of strategic alliances is a notable trend in the contrast media injectors market, with major industry players forming collaborations focused on comparable product development. A prime example of this is the December 2022 partnership between Qaelum NV, an advanced dose and contrast management software solutions firm from Belgium, and Ulrich GmbH & Company KG., a surgical instrument manufacturer and distributor based in France. Through this collaboration, the two companies plan to integrate Qaelum's innovative contrast management solution with Ulrich Medical's contrast media injectors to better cater to the requirements of hospitals and imaging networks.
Who Are the Key Players in the Contrast Media Injectors Market?
Major companies operating in the contrast media injectors market include:
• The Bracco Group
• Bayer AG
• Medtron AG
• Ulrich GmbH And Co. KG
• General Electric Company
• Nemoto Kyorindo Co. Ltd.
• Guerbet Group
• Sino Medical-Device Technology Co. Ltd
• Apollo RT Co.Ltd
• Shenzhen Anke High-tech Co. Ltd
• Vivid Imaging
• AngioDynamics. Inc.
• Medrad Inc.
• TaeWoong Medical Co. Ltd.
• Medtronic Plc
• ACIST Medical Systems
• Boston Scientific Corporation
• Mallinckrodt Pharmaceuticals
• Lantheus Medical Imaging Inc.
• Imaxeon Pty Ltd.
What are the Regional Insights into the Contrast Media Injectors Market?
North America was the largest region in the contrast media injectors market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global contrast media injectors market report during the forecast period. The regions covered in the contrast media injectors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
